European Respiratory Journal

Static mucus impairs bacterial clearance and allows chronic infection with Pseudomonas aeruginosa in the cystic fibrosis rat. 2022

Evaluation of a novel CFTR potentiator in copd ferrets with acquired cftr dysfunction. 2021

AICAR Decreases Acute Lung injury by Phosphorylating AMPK and Upregulating Heme Oxygenase-1.  58. 2021

A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.  58. 2021

A novel locus for exertional dyspnoea in childhood asthma.  57. 2021

A genome-wide association study of severe asthma exacerbations in Latino children and adolescents.  57. 2021

Cyclosporine: An old weapon in the fight against coronaviruses.  56. 2020

The effect of exacerbation history on outcomes in the impact trial.  55. 2020

Physiological predictors of survival in patients with sarcoidosis associated pulmonary hypertension: Results from an international registry.  55. 2020

Pulmonary artery enlargement and mortality risk in moderate to severe COPD: Results from COPDGene.  55. 2020

Can animal models really teach us anything about pneumonia? Pro.  55. 2020

Excess mucus viscosity and airway dehydration impact COPD airway clearance.  55. 2020

Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.  54. 2019

Misinterpretation of time-to-first event curves can lead to inappropriate treatment.  54. 2019

Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.  54. 2019

Physical activity and quality of life in patients with pulmonary hypertension.  53. 2019

Effect of daily azithromycin therapy and adherence on readmission risk in COPD.  53. 2019

Inflammation and endothelial activation in early adulthood are associated with future emphysema: The CARDIA Lung Study.  53. 2019

Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry.  53. 2019

Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS.  52. 2018

Fibroblast growth factor 23 and Klotho contribute to airway inflammation.  52. 2018

A clean sweep: Mucin bundles clear the airway.  52. 2018

Cigarette smoking and response to inhaled corticosteroids in COPD.  51. 2018

ERS/ATS workshop report on respiratory health effects of household air pollution.  51. 2018

Variable radiological lung nodule evaluation leads to divergent management recommendations.  52:1-12. 2018

Chest computed tomography-derived low fat-free mass index and mortality in COPD.  50. 2017

Airway microbiota across age and disease spectrum in cystic fibrosis..  50. 2017

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study.  50. 2017

High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis.  50. 2017

In Rotterdam, size really does matter: Implications of pulmonary artery enlargement on mortality.  49. 2017

Doxycycline improves clinical outcomes during cystic fibrosis exacerbations.  49. 2017

High attenuation areas on chest computed tomography in communitydwelling adults: The MESA study.  48:1442-1452. 2016

Beta-blockers in COPD: Time for reappraisal.  48:880-888. 2016

A phase III randomised controlled trial of single-dose triple therapy in COPD: The IMPACT protocol.  48:320-330. 2016

FG-3019 anti-connective tissue growth factor monoclonal antibody: Results of an open-label clinical trial in idiopathic pulmonary fibrosis.  47:1481-1491. 2016

Sex-specific features of emphysema among current and former smokers with COPD.  47:104-112. 2016

Continuous fat-free mass decline in COPD: Fact or fiction?.  46:1496-1498. 2015

A randomised trial of lung sealant versus medical therapy for advanced emphysema.  46:651-662. 2015

Outcomes of β-blocker use in pulmonary arterial hypertension: A propensity-matched analysis.  46:750-760. 2015

The clinical and genetic features of COPD-asthma overlap syndrome.  44:341-350. 2014

Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.  43:1448-1458. 2014

Pulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus.  43:1086-1096. 2014

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis.  44:1296-1307. 2014

Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe.  43:166-177. 2014

Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial.  43:295-298. 2014

Macitentan for the treatment of idiopathic pulmonary fibrosis: The randomised controlled MUSIC trial.  42:1622-1632. 2013

CFTR biomarkers: Time for promotion to surrogate end-point?.  41:203-216. 2013

The risk of tuberculosis in transplant candidates and recipients: A TBNET consensus statement.  40:990-1013. 2012

CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung disease.  39:1385-1390. 2012

Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis.  39:133-140. 2012

Series "matrix metalloproteinases in lung health and disease": The role of matrix metalloproteinases in cystic fibrosis lung disease.  38:721-727. 2011

Lean mass predicts asthma better than fat mass among females.  37:65-71. 2011

Combined airway and oesophageal stenting in malignant airway-oesophageal fistulas: A prospective study.  36:1370-1374. 2010

Biologic lung volume reduction therapy for advanced homogeneous emphysema.  36:20-27. 2010

Inhibition of airway proteases in cystic fibrosis lung disease.  32:783-795. 2008

Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma.  31:43-46. 2008

Erratum: "Talc mediates angiostasis in malignant pleural effusions via endostatin induction" (European Respiratory Journal (2007) vol. 29 (761-769)).  29:1286. 2007

Talc mediates angiostasis in malignant pleural effusions via endostatin induction.  29:761-769. 2007

Immunological mechanisms in pleural disease.  21:539-544. 2003

Management of malignant pleural effusions.  18:402-419. 2001

Immunobiology of pleural inflammation: Potential implications for pathogenesis, diagnosis and therapy.  10:2411-2418. 1997

Pleurodesis: State of the art.  10:1648-1654. 1997

Alveolar cell population in HIV infected patients.  4:639-642. 1991